Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Nemaura Medical Inc. NMRD
$0.70
-$0.01 (-0.87%)
На 18:01, 12 мая 2023
+1 042.86%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
21102342.00000000
-
week52high
3.43
-
week52low
0.70
-
Revenue
503906
-
P/E TTM
-1
-
Beta
-0.06124500
-
EPS
-0.60000000
-
Last Dividend
0.00000000
-
Next Earnings Date
27 июн 2023 г. в 20:00
Описание компании
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 19 авг 2022 г. |
| HC Wainwright & Co. | Buy | 29 мар 2022 г. | |
| EF Hutton | Buy | 02 дек 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Mclarney Justin James | A | 22293 | 22293 | 31 янв 2022 г. |
| Natha Salim | A | 8000 | 8000 | 28 янв 2022 г. |
| Moore Thomas Peter | A | 8000 | 8000 | 28 янв 2022 г. |
| Timol Bashir | A | 8000 | 8000 | 28 янв 2022 г. |
| Chowdhury Dewan Fazlul Hoque | A | 8000 | 8000 | 28 янв 2022 г. |
| Johnson Timothy Christopher | A | 8000 | 8000 | 28 янв 2022 г. |
| Ismail Sufyan | D | 0 | 22705 | 05 июн 2018 г. |
| Ismail Sufyan | A | 22705250 | 22705000 | 05 июн 2018 г. |
| Timol Bashir | D | 0 | 27082 | 05 июн 2018 г. |
| Timol Bashir | A | 27082100 | 27082000 | 05 июн 2018 г. |
Новостная лента
Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference
GlobeNewsWire
16 февр 2023 г. в 08:15
Loughborough, England, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, announces that CEO Dr. Faz Chowdhury will participate in a fireside chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference that is being held virtually on February 21 – 24, 2023.
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
GlobeNewsWire
11 янв 2023 г. в 08:00
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, announces that CEO Dr. Faz Chowdhury will present a corporate overview at the Sidoti & Co. Micro Cap Virtual Conference being held on January 18 -19, 2023.
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
GlobeNewsWire
01 дек 2022 г. в 08:15
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 – 8, 2022.
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
GlobeNewsWire
11 ноя 2022 г. в 08:00
Loughborough, England, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at at the Bernstein 2nd Annual CGM Disruptors Conference which is being held virtually on November 18, 2022.
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 08:30
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference, which is being held on September 12 – 14, 2022.